- Home
- EPIX vs ASRT Comparison
EPIX vs ASRT Comparison
Compare EPIX & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPIX
- ASRT
- Stock Information
- Founded
- EPIX 2009
- ASRT 1995
- Country
- EPIX Canada
- ASRT United States
- Employees
- EPIX N/A
- ASRT N/A
- Industry
- EPIX Biotechnology: Pharmaceutical Preparations
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- EPIX Health Care
- ASRT Health Care
- Exchange
- EPIX Nasdaq
- ASRT Nasdaq
- Market Cap
- EPIX 77.2M
- ASRT 85.1M
- IPO Year
- EPIX N/A
- ASRT 1997
- Fundamental
- Price
- EPIX $1.75
- ASRT $0.83
- Analyst Decision
- EPIX Hold
- ASRT Strong Buy
- Analyst Count
- EPIX 3
- ASRT 4
- Target Price
- EPIX $2.00
- ASRT $3.19
- AVG Volume (30 Days)
- EPIX 425.3K
- ASRT 634.7K
- Earning Date
- EPIX 02-11-2025
- ASRT 03-10-2025
- Dividend Yield
- EPIX N/A
- ASRT N/A
- EPS Growth
- EPIX N/A
- ASRT N/A
- EPS
- EPIX N/A
- ASRT N/A
- Revenue
- EPIX N/A
- ASRT $125,763,000.00
- Revenue This Year
- EPIX N/A
- ASRT N/A
- Revenue Next Year
- EPIX N/A
- ASRT $1.84
- P/E Ratio
- EPIX N/A
- ASRT N/A
- Revenue Growth
- EPIX N/A
- ASRT N/A
- 52 Week Low
- EPIX $1.40
- ASRT $0.73
- 52 Week High
- EPIX $11.67
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- EPIX 41.97
- ASRT 42.81
- Support Level
- EPIX $1.70
- ASRT $0.78
- Resistance Level
- EPIX $1.85
- ASRT $0.94
- Average True Range (ATR)
- EPIX 0.10
- ASRT 0.05
- MACD
- EPIX 0.03
- ASRT -0.00
- Stochastic Oscillator
- EPIX 43.66
- ASRT 29.56
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.